A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects with Erythropoietic Protoporphyria

  • Anderson, Karl (PI)

Project: Other project

Project Details

StatusFinished
Effective start/end date6/6/1811/30/20